Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,711 | 191 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $1,262 | 65 | $0 (2024) |
| ABBVIE INC. | $1,252 | 67 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $605.93 | 34 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $307.15 | 12 | $0 (2024) |
| Ipsen Biopharmaceuticals, Inc | $154.34 | 7 | $0 (2024) |
| Madrigal Pharmaceuticals | $88.61 | 4 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $22.39 | 1 | $0 (2022) |
| Dova Pharmaceuticals | $18.11 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $848.66 | 41 | Gilead Sciences, Inc. ($305.33) |
| 2023 | $814.66 | 44 | Gilead Sciences, Inc. ($382.45) |
| 2022 | $1,026 | 55 | Gilead Sciences, Inc. ($352.22) |
| 2021 | $1,022 | 51 | AbbVie Inc. ($572.64) |
All Payment Transactions
191 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: LIVER DISEASE | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.89 | General |
| 12/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: VIROLOGY | ||||||
| 12/02/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: Rare Disease | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.90 | General |
| 11/14/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: LIVER DISEASE | ||||||
| 11/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: VIROLOGY | ||||||
| 11/04/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Rare Disease | ||||||
| 10/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: VIROLOGY | ||||||
| 10/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: LIVER DISEASE | ||||||
| 10/10/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Rare Disease | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: LIVER DISEASE | ||||||
| 10/03/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.60 | General |
| 09/25/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: VIROLOGY | ||||||
| 09/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.44 | General |
| 08/28/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $4.71 | General |
| 08/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: VIROLOGY | ||||||
| 08/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Gastroenterology | ||||||
| 08/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.06 | General |
| 07/24/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: VIROLOGY | ||||||
| 07/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.45 | General |
| 07/08/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 06/12/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Rare Disease | ||||||
| 06/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $20.88 | General |
| 05/13/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 236 | 303 | $48,602 | $14,016 |
| 2022 | 3 | 236 | 318 | $34,644 | $13,547 |
| 2021 | 3 | 258 | 348 | $33,404 | $14,740 |
| 2020 | 5 | 316 | 395 | $32,869 | $13,097 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 165 | $39,306 | $11,525 | 29.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 20 | $3,369 | $1,008 | 29.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 83 | 107 | $1,819 | $886.08 | 48.7% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 11 | 11 | $4,107 | $596.39 | 14.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 151 | $28,672 | $11,644 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 32 | $3,677 | $1,504 | 40.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 94 | 135 | $2,295 | $400.17 | 17.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 144 | $24,480 | $11,021 | 45.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 62 | $6,510 | $3,296 | 50.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 94 | 142 | $2,414 | $423.06 | 17.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 142 | 174 | $18,270 | $7,436 | 40.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 48 | 57 | $9,690 | $4,001 | 41.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 20 | $1,390 | $871.46 | 62.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 16 | 17 | $1,360 | $412.31 | 30.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 91 | 127 | $2,159 | $376.43 | 17.4% |
About Cynthia Wheeler, ACNP-BC
Cynthia Wheeler, ACNP-BC is a Acute Care healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2011. The National Provider Identifier (NPI) number assigned to this provider is 1265721419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Cynthia Wheeler, ACNP-BC has received a total of $3,711 in payments from pharmaceutical and medical device companies, with $848.66 received in 2024. These payments were reported across 191 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($3,711).
As a Medicare-enrolled provider, Wheeler has provided services to 1,046 Medicare beneficiaries, totaling 1,364 services with total Medicare billing of $55,400. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Acute Care
- Location Nashville, TN
- Active Since 03/28/2011
- Last Updated 04/12/2022
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1265721419
Products in Payments
- MAVYRET (Drug) $1,218
- XIFAXAN (Drug) $605.93
- OCALIVA (Drug) $307.15
- RESMETIROM (Drug) $88.61
- IQIRVO (Drug) $86.83
- Bylvay (Drug) $67.51
- TERLIVAZ (Drug) $22.39
- VIEKIRA PAK (Drug) $20.98
- Doptelet (Drug) $18.11
- CREON (Drug) $13.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Nashville
Haley Hoy, Aprn, APRN
Acute Care — Payments: $188,693
Barbara Brown, Dnp Acnp-Bc Fnp, DNP ACNP-BC FNP
Acute Care — Payments: $36,223
Shannon Grace, Np, NP
Acute Care — Payments: $33,393
Elizabeth Davidson, Acnp, ACNP
Acute Care — Payments: $32,699
Dr. Tisha Barzyk, Dnp, Agacnp-Bc, Cws, DNP, AGACNP-BC, CWS
Acute Care — Payments: $22,476
Ms. Krista Kuhnert-Gainer, Aprn, APRN
Acute Care — Payments: $17,208